Supernus Pharmaceuticals SUPN
NASDAQ SUPN
$42.18 -0.86 (-2.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Supernus Pharmaceuticals (SUPN) Non-Current Deferred Tax Liability (2015 - 2025)

Updated

Supernus Pharmaceuticals' Non-Current Deferred Tax Liability was $981,000 in Q1 2025, down 95.0% from $19.5 million a year earlier and down 80.2% from the prior quarter.

Analysis

Supernus Pharmaceuticals (SUPN) Non-Current Deferred Tax Liability (2015 - 2025) Analysis & Trends

At the end of FY2024, Non-Current Deferred Tax Liability at Supernus Pharmaceuticals came in at $4.96 million, down 80.1% from FY2023.

  • Non-Current Deferred Tax Liability has now declined for three consecutive years, with a four-year compound annual growth rate of -38.7% (FY2020 to FY2024).
  • In earlier years, Non-Current Deferred Tax Liability was $24.96 million in FY2023 (-49.9%), $49.81 million in FY2022 (-41.6%), $85.36 million in FY2021 (+142.4%) and $35.22 million in FY2020.
  • The Q1 2025 figure marks the lowest quarterly Non-Current Deferred Tax Liability since Q4 2015.
  • Compared with a year earlier, Non-Current Deferred Tax Liability has declined for ten straight quarters, with an average decline of 63.0% over the last eight quarters.
  • The best year-over-year quarter for Non-Current Deferred Tax Liability over five years was Q4 2021 (growth of 142.4%); the worst was Q1 2025 (a decline of 95.0%).
  • Per Business Quant data, SUPN's Non-Current Deferred Tax Liability in the three quarters before Q1 2025 was $4.96 million (Q4 2024), $7.36 million (Q3 2024) and $11.44 million (Q2 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Supernus Pharmaceuticals 2.50 Bn 1.16 Bn 185.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 981,000.00
Dec 31, 2024 4.96 Mn
Sep 30, 2024 7.36 Mn
Jun 30, 2024 11.44 Mn
Mar 31, 2024 19.50 Mn
Dec 31, 2023 24.96 Mn
Sep 30, 2023 35.22 Mn
Jun 30, 2023 44.30 Mn
Mar 31, 2023 49.67 Mn
Dec 31, 2022 49.81 Mn
Sep 30, 2022 58.16 Mn
Jun 30, 2022 59.31 Mn
Mar 31, 2022 62.84 Mn
Dec 31, 2021 85.36 Mn
Sep 30, 2021 34.15 Mn
Jun 30, 2021 32.99 Mn
Mar 31, 2021 31.74 Mn
Dec 31, 2020 35.22 Mn
Sep 30, 2020 37.94 Mn
Jun 30, 2020 35.72 Mn
API Access

Supernus Pharmaceuticals Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=SUPN&period=max&api_key=YOUR_API_KEY